News & Publications for:

Aaron DiAntonio

AAAS names 7 Washington University faculty as 2020 fellows

Posted on November 24, 2020

Four of the newly named fellows are School of Medicine faculty Read More

Posted in: Axon Injury & Repair, Clocks & Sleep, HPAN, Neurodegeneration, News Faculty: , ,

Startup company founded by Washington University scientists acquired by Eli Lilly

Posted on October 21, 2020

Drugmaker purchases Disarm Therapeutics to develop treatments for neurodegenerative diseases Read More

Posted in: Axon Injury & Repair, News Faculty: ,

SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration

Posted on July 14, 2020

Kwang Woo Ko, Jeffrey Milbrandt, Aaron DiAntonio. The Journal of Cell Biology, Volume 219, Issue 8, 3 August 2020 Read More

Posted in: Axon Injury & Repair, Publications Faculty: ,

Models of Axon Degeneration in Drosophila Larvae

Posted on June 23, 2020

E. J. Brace, Aaron DiAntonio. Methods in Molecular Biology (Clifton, N.J.), Volume 2143, 2020, Pages 311-320 Read More

Posted in: Axon Injury & Repair, Publications Faculty:

cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons

Posted on April 21, 2020

Yo Sasaki,Thomas M. Engber, Robert O. Hughes, Matthew D. Figley, Tong Wu, Todd Bosanac, Rajesh Devraj, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio. Experimental Neurology, Volume 329, July 2020, Article number 113252 Read More

Posted in: Axon Injury & Repair, Publications Faculty: ,